Village Farms (VFF) Q3 2026 Earnings Call Transcript

Image source: The Motley Fool.

DATE

Mon, Nov. 9, 2026

CALL PARTICIPANTS

• President and Chief Executive Officer – Michael A. DeGiglio
• Interim Chief Financial Officer – Hamid Shekarchi
• Chief Operating Officer – Ann Gillin Lefever
• Senior Vice President of Corporate Affairs and Investor Relations – Sam Gibbons
• Executive Vice President and Corporate Secretary – Stephen Ruffini

TAKEAWAYS

• Consolidated Net Sales — $66.9 million, representing a 5% sequential increase driven by record cannabis revenue.
• Cannabis Segment Revenue — $55.0 million, growing 3% year over year and reaching a new quarterly record.
• International Export Sales — $20.8 million, increasing 75% year over year due to demand in European markets.
• Net Income — $9.9 million, resulting in earnings of $0.08 per share.
• Adjusted EBITDA — $18.2 million, or 27% of sales, improving 18% sequentially from the second quarter.
• Cash and Cash Equivalents — $79.3 million, an increase of $6.3 million from the previous quarter.
• Operating Cash Flow — $9.5 million for the third quarter, reflecting stronger second-half free cash flow.
• Canadian Branded Sales — $25.3 million, a 6% year-over-year decline attributed to lower value brand volumes.
• Canadian Non-Branded Sales — $3.3 million, falling from $7.3 million last year due to a softer wholesale trim market.
• Netherlands Sales — $2.8 million, impacted by increased plant propagation activities at the Phase 2 facility.
• U.S. Cannabis Revenue — $2.8 million, reflecting challenges from unregulated intoxicating hemp products and state restrictions.
• Cannabis Gross Margin — 48%, compared to 55% in the prior year period, driven by lower trim pricing.
• Trim Spot Pricing — Down 75% year over year, which management described as a trough level for the industry.
• Delta 2 Expansion Capacity — 40 metric tons, with the facility expected to reach full annual run rate by mid-2027.
• Delta 1 Conversion Right — 16 acres, providing the option to activate 700,000 square feet of production in 2027.
• Monahans Facility Size — 30 acres, consisting of a 1.3 million-square-foot greenhouse in Texas.
• Total Long-term Debt — $39.0 million, with a weighted-average interest rate of 5.7%.
• Canadian Excise Tax — $16.5 million, representing 39% of gross branded cannabis sales.
• Year-to-Date Adjusted EBITDA — $43.5 million, up 18% when excluding a one-time settlement from the previous year.
• Capital Expenditures — $17.3 million year to date, focused on Delta 2 and Groningen expansions.
• Average Net Selling Price (International) — Down 9% year over year, entirely driven by a mix shift to bulk-flower sales.
• Monahans Activation Timeline — 12 months, reflecting the estimated time to operationalize the Texas facility for cannabis production.

Need a quote from a Motley Fool analyst? Email [email protected]

RISKS

• Shekarchi stated, “European order volume slowed significantly over the holiday period in Q4 and resulted in a sequential revenue decline compared to the third quarter,” indicating potential seasonal volatility in international sales.
• Shekarchi warned that contracted produce sales from the Delta 1 greenhouse typically peak in the second and third quarters and declined 60% in the fourth quarter of the previous year.
• Management stated that U.S. cannabis operations continue to face challenges created by “unregulated intoxicating hemp products and related state regulatory restrictions.”

SUMMARY

Village Farms International, Inc. (VFF -1.39%) reported record quarterly cannabis revenue of $55 million, with international export sales growing 75% year over year. Management reported that consolidated net sales reached $66.9 million while adjusted EBITDA improved 18% sequentially to $18.2 million. The company reported net income of $9.9 million and a cash position of approximately $80 million as of Sept. 30. Strategic efforts are focused on mobilizing production assets in Texas and expanding cultivation capacity in British Columbia and the Netherlands to meet global demand for pharmaceutical-grade cannabis.

• CEO DeGiglio indicated that midterm elections in Texas shifted the regulatory landscape, stating, “we are actively mobilizing plans to operationalize our stand alone 30-acre 1.3-million-square-foot greenhouse in Monahans, Texas for cannabis production.”
• The company is focusing on EU GMP certification at the source to mitigate late-supply-chain certification, with CEO DeGiglio stating, “If GMP washing continues to be curtailed… the market for truly at the source compliant product could face shortages very quickly.”
• Management reported that several Canadian competitors are de-emphasizing branded sales or exiting the dry flower category, which improves the competitive landscape for the company.
• The Delta 2 expansion in British Columbia is on track for completion in the first quarter of 2027 and is expected to reach its full 40 metric ton annual run rate by mid-2027.
• The company exercised its right to convert 25% of the Delta 1 greenhouse to cannabis production in 2027, providing optionality for an additional 700,000 square feet of capacity.
• In the Netherlands, the Groningen facility is now fully planted and is expected to begin driving stronger revenue growth in the fourth quarter.

INDUSTRY GLOSSARY

• EU GMP: European Union Good Manufacturing Practice, a pharmaceutical quality standard required for medical cannabis imports into Europe.
• Adjusted EBITDA: A financial metric that excludes non-recurring items, amortization, depreciation, and taxes to measure core operational performance.
• Trim: Leaves and small stems removed from cannabis flowers during harvesting, typically sold wholesale for extraction.
• Excise Tax: A specialized tax applied to cannabis products in Canada, often calculated per gram or as a percentage of the selling price.
• Propagation: The process of breeding or growing plants from seeds or cuttings, which can temporarily reduce production volumes during facility ramp-ups.
• Schedule 3: A classification under the U.S. Controlled Substances Act for drugs with moderate to low potential for physical and psychological dependence.

Full Conference Call Transcript

Operator: Good day, and thank you for standing by. Welcome to the Village Farms International Third Quarter 26 Earnings Conference Call. At this time, all participants are in a listen-only mode. Later, we will conduct a question-and-answer session. Star 1 on your telephone. You will then hear an automated message advising that your hand is raised. To withdraw your question, please press star 1 again. Please be advised that today’s conference is being recorded. I would now like to hand the conference over to your first speaker, Michael DeGiglio. Please go ahead.

Michael A. DeGiglio: Thank you, Tanya. And good morning, everyone, and thank you for

Source: www.fool.com — article syndicated from the publisher’s feed; all rights remain with the original publisher.